ICON and Tigermed Consulting, a provider of clinical drug development services in China, have signed an alliance agreement. The two companies will collaborate to offer clients better access to Chinese patients using ICON’s experience and global reach along with Tigermed’s knowledge of the Chinese drug development landscape and geographic coverage in China. Tigermed, headquartered in Shanghai, has 21 offices in China and more than 300 clinical development staff. “Tigermed has a substantial cli...